SCHEMBL6594140

SCHEMBL6594140

Nc1ccc(F)cc1C(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 4/20 0.72
P2RX1 P51575 3/20 0.58
RAB9A P51151 4/20 0.55
NPC1 O15118 3/20 0.55
ALDH1A1 P00352 1/20 0.54
LMNA P02545 1/20 0.54
GAA P10253 1/20 0.54
KMT2A Q03164 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
MAPK1 P28482 1/20 0.52
HTT P42858 1/20 0.52
HDAC1 Q13547 3/20 0.52
BRAF P15056 2/20 0.52
KEAP1 Q14145 1/20 0.51
F10 P00742 2/20 0.50
PNLIP P16233 1/20 0.48
P2RX4 Q99571 1/20 0.48
P2RX7 Q99572 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6593295 0.88 P2RX1 (0.58) FADS1P2RX1RAB9ANPC1ALDH1A1
SCHEMBL6587131 0.87 FADS1 (0.74) FADS1P2RX1ALDH1A1LMNAHDAC1
SCHEMBL12885792 0.84 FADS1 (0.72) FADS1P2RX1RAB9ANPC1ALDH1A1
SCHEMBL6590611 0.83 NPC1 (0.58) FADS1P2RX1RAB9ANPC1ALDH1A1
SCHEMBL3157341 0.82 RAB9A (0.61) FADS1RAB9ANPC1ALDH1A1LMNA
SCHEMBL6589803 0.82 FADS1 (0.58) FADS1P2RX1KMT2AMAPK1HDAC1
SCHEMBL5222830 0.81 BRAF (0.59) FADS1RAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL10243995 0.81 FADS1 (0.57) FADS1P2RX1KMT2AHDAC1BRAF
SCHEMBL1351311 0.81 FADS1 (0.57) FADS1P2RX1RAB9ANPC1SMN1; SMN2
SCHEMBL6593129 0.81 FADS1 (0.60) FADS1P2RX1RAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1143855-C I (ortho)-anthranilamide derivatives as anti-coagulants ���ֹɷݹ�˾ 2004-03-31 CN disclosed
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP disclosed
US-6498185-B1 ENZYME FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. 2002-12-24 US disclosed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US disclosed
CN-1282329-A I (ortho)-anthranilamide derivatives as anti-coagulants SCHERING AG (DE) 2001-01-31 CN disclosed
US-6140351-A FOR TREATING THROMBOSIS BERLEX LABORATORIES, INC. (US) 2000-10-31 US disclosed